PFG Investments LLC Acquires Shares of 3,274 GeneDx Holdings Corp. (NASDAQ:WGS)
PFG Investments LLC bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 3,274 shares of ...
Nisa Investment Advisors LLC Grows Position in GeneDx Holdings Corp. (NASDAQ:WGS)
Nisa Investment Advisors LLC grew its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 147,085.3% ...
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green
Key Insights Institutions' substantial holdings in GeneDx Holdings implies that they have significant influence ...
Craig-Hallum Keeps Their Buy Rating on GeneDx Holdings (WGS)
Craig-Hallum analyst William Bonello maintained a Buy rating on GeneDx Holdings (WGS – Research Report) today. The company’s shares closed ...
Seeking Alpha16d
GeneDx Holdings: A Phenomenal Comeback With More Room To Run
GeneDx Holdings Corp. experienced a dramatic turnaround in 2024, achieving profitability and 100x returns, driven by reduced cash burn and strategic product innovations. Key growth catalysts ...
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, continues its investment in ...
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today ...
GeneDx anticipates higher-than-expected annual revenues
GeneDx Holdings (NASDAQ:WGS) expects to exceed guidance with full year 2024 revenues of at least $299M ($288.20M estimate) ...
Seeking Alpha19d
GeneDx anticipates higher-than-expected annual revenues
GeneDx Holdings (NASDAQ:WGS) expects to exceed guidance with full year 2024 revenues of at least $299M ($288.20M estimate) and adjusted gross margin of at least 64% (previous guidance was at least ...